About this Journal Submit a Manuscript Table of Contents
Journal of Biomedicine and Biotechnology
Volume 2012 (2012), Article ID 984589, 7 pages
http://dx.doi.org/10.1155/2012/984589
Research Article

Characterization of Plasminogen Binding to NB4 Promyelocytic Cells Using Monoclonal Antibodies against Receptor-Induced Binding Sites in Cell-Bound Plasminogen

1Cell Biology Department, Pompeu Fabra University, Barcelona, Spain
2Centre de Diagnòstic Genètic Molecular, Hospital Duran i Reynals, 08907 L'Hospitalet de Llobregat, Spain
3Centre Atenció Primària (CAP) Canaletes, Institut Català de la Salut (ICS), Passeig d'Horta 17, 08290 Cerdanyola del Vallès, Spain

Received 24 April 2012; Accepted 6 June 2012

Academic Editor: Lindsey A. Miles

Copyright © 2012 Mercè Jardí et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Collen and H. R. Lijnen, “Basic and clinical aspects of fibrinolysis and thrombolysis,” Blood, vol. 78, no. 12, pp. 3114–3124, 1991. View at Scopus
  2. E. F. Plow, J. Felez, and L. A. Miles, “Cellular regulation of fibrinolysis,” Thrombosis and Haemostasis, vol. 66, no. 1, pp. 32–36, 1991. View at Scopus
  3. E. F. Plow and L. A. Miles, “Plasminogen receptors in the mediation of pericellular proteolysis,” Cell Differentiation and Development, vol. 32, no. 3, pp. 293–298, 1990. View at Publisher · View at Google Scholar · View at Scopus
  4. E. F. Plow, T. Herren, A. Redlitz, L. A. Miles, and J. L. Hoover-Plow, “The cell biology of the plasminogen system,” The FASEB Journal, vol. 9, no. 10, pp. 939–945, 1995. View at Scopus
  5. V. Sinniger, R. E. Mertont, P. Fabregas, J. Felez, and C. Longstaff, “Regulation of tissue plasminogen activator activity by cells: domains responsible for binding and mechanism of stimulation,” The Journal of Biological Chemistry, vol. 274, no. 18, pp. 12414–12422, 1999. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Longstaff, R. E. Merton, P. Fabregas, and J. Felez, “Characterization of cell-associated plasminogen activation catalyzed by urokinase-type plasminogen activator, but independent of urokinase receptor (uPAR, CD87),” Blood, vol. 93, no. 11, pp. 3839–3846, 1999. View at Scopus
  7. A. Redlitz, B. J. Fowler, E. F. Plow, and L. A. Miles, “The role of an enolase-related molecule in plasminogen binding to cells,” European Journal of Biochemistry, vol. 227, no. 1-2, pp. 407–415, 1995. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Felez, “Plasminogen binding to cell surfaces,” Fibrinolysis and Proteolysis, vol. 12, no. 4, pp. 183–189, 1998. View at Scopus
  9. T. Herren, T. A. Burke, M. Jardi, J. Felez, and E. F. Plow, “Regulation of plasminogen binding to neutrophils,” Blood, vol. 97, no. 4, pp. 1070–1078, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. R. P. Warrell, H. de Thé, Z. Y. Wang, and L. Degos, “Acute promyelocytic leukemia,” The New England Journal of Medicine, vol. 329, no. 3, pp. 177–189, 1993. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Degos, “The history of acute promyelocytic leukaemia,” British Journal of Haematology, vol. 122, no. 4, pp. 539–553, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. J. S. Menell, G. M. Cesarman, A. T. Jacovina, M. A. McLaughlin, E. A. Lev, and K. A. Hajjar, “Annexin II and bleeding in acute promyelocytic leukemia,” The New England Journal of Medicine, vol. 340, no. 13, pp. 994–1004, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Devy, P. Hollender, C. Munaut et al., “Matrix and serine protease expression during leukemic cell differentiation induced by aclacinomycin and all-trans-retinoic acid,” Biochemical Pharmacology, vol. 63, no. 2, pp. 179–189, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Tapiovaara, S. Matikainen, M. Hurme, and A. Vaheri, “Induction of differentiation of promyelocytic NB4 cells by retinoic acid is associated with rapid increase in urokinase activity subsequently downregulated by production of inhibitors,” Blood, vol. 83, no. 7, pp. 1883–1891, 1994. View at Scopus
  15. T. Barbui, G. Finazzi, and A. Falanga, “The impact of all-trans-retinoic acid on the coagulopathy of acute promyelocytic leukemia,” Blood, vol. 91, no. 9, pp. 3093–3102, 1998. View at Scopus
  16. J. Han, N. Baik, K. H. Kim et al., “Monoclonal antibodies detect receptor-induced binding sites in Glu-plasminogen,” Blood, vol. 118, no. 6, pp. 1653–1662, 2011. View at Publisher · View at Google Scholar
  17. L. A. Miles and E. F. Plow, “Binding and activation of plasminogen on the platelet surface,” The Journal of Biological Chemistry, vol. 260, no. 7, pp. 4303–4311, 1985. View at Scopus
  18. L. A. Miles, M. H. Ginsberg, J. G. White, and E. F. Plow, “Plasminogen interacts with human platelets through two distinct mechanisms,” Journal of Clinical Investigation, vol. 77, no. 6, pp. 2001–2009, 1986. View at Scopus
  19. L. A. Miles, C. M. Dahlberg, and E. F. Plow, “The cell-binding domains of plasminogen and their function in plasma,” The Journal of Biological Chemistry, vol. 263, no. 24, pp. 11928–11934, 1988. View at Scopus
  20. J. Felez, L. A. Miles, J. Plescia, and E. F. Plow, “Regulation of plasminogen receptor expression on human monocytes and monocytoid cell lines,” Journal of Cell Biology, vol. 111, no. 4, pp. 1673–1683, 1990. View at Scopus
  21. J. Félez, L. A. Miles, P. Fábregas, M. Jardí, E. F. Plow, and R. H. Lijnen, “Characterization of cellular binding sites and interactive regions within reactants required for enhancement of plasminogen activation by tPA on the surface of leukocytic cells,” Thrombosis and Haemostasis, vol. 76, no. 4, pp. 577–584, 1996. View at Scopus
  22. J. M. Bennett, D. Catovsky, M. T. Daniel et al., “Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group,” Annals of Internal Medicine, vol. 103, no. 4, pp. 620–625, 1985. View at Scopus
  23. R. W. Stephens, J. Pöllänen, H. Tapiovaara et al., “Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants,” Journal of Cell Biology, vol. 108, no. 5, pp. 1987–1995, 1989. View at Scopus
  24. V. Ellis, N. Behrendt, and K. Danø, “Plasminogen activation by receptor-bound urokinase: a kinetic study with both cell-associated and isolated receptor,” The Journal of Biological Chemistry, vol. 266, no. 19, pp. 12752–12758, 1991. View at Scopus
  25. G. M. Cesarman, C. A. Guevara, and K. A. Hajjar, “An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation,” The Journal of Biological Chemistry, vol. 269, no. 33, pp. 21198–21203, 1994. View at Scopus
  26. M. Kwon, T. J. MacLeod, Y. Zhang, and D. M. Waisman, “S100A10, annexin A2, and annexin A2 heterotetramer as candidate plasminogen receptors,” Frontiers in Bioscience, vol. 10, no. 1, pp. 300–325, 2005. View at Scopus
  27. M. P. Stoppelli, C. Tacchetti, M. V. Cubellis et al., “Autocrine saturation of pro-urokinase receptors on human A431 cells,” Cell, vol. 45, no. 5, pp. 675–684, 1986. View at Scopus
  28. J. Félez, M. Jardí, P. Fàbregas, R. J. Parmer, and L. A. Miles, “Monoclonal antibodies against receptor-induced binding sites detectcell-bound plasminogen in blood,” Blood, vol. 120, no. 3, pp. 678–681, 2012. View at Publisher · View at Google Scholar
  29. P. A. O'Connell, P. A. Madureira, J. N. Berman, R. S. Liwski, and D. M. Waisman, “Regulation of S100A10 by the PML-RAR-α oncoprotein,” Blood, vol. 117, no. 15, pp. 4095–4105, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. S. A. Olwill, H. McGlynn, W. S. Gilmore, and H. D. Alexander, “Erratum: all-trans retinoic acid-induced downregulation of annexin II expression in myeloid leukaemia cell lines is not confined to acute promyelocytic leukaemia (British Journal of Haematology (2005) 131 (258–264)),” British Journal of Haematology, vol. 132, no. 1, p. 119, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. S. A. Olwill, H. McGlynn, W. S. Gilmore, and H. D. Alexander, “Annexin II cell surface and mRNA expression in human acute myeloid leukaemia cell lines,” Thrombosis Research, vol. 115, no. 1-2, pp. 109–114, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. P. Surette, P. A. Madureira, K. D. Phipps, V. A. Miller, P. Svenningsson, and D. M. Waisman, “Regulation of fibrinolysis by S100A10 in vivo,” Blood, vol. 118, no. 11, pp. 3172–3181, 2011. View at Publisher · View at Google Scholar
  33. P. A. Madureira, A. P. Surette, K. D. Phipps, M. A. Taboski, V. A. Miller, and D. M. Waisman, “The role of the annexin A2 heterotetramer in vascular fibrinolysis,” Blood, vol. 118, no. 18, pp. 4789–4797, 2011. View at Publisher · View at Google Scholar
  34. L. A. Miles, C. M. Dahlberg, J. Plescia, J. Felez, K. Kato, and E. F. Plow, “Role of cell-surface lysines in plasminogen binding to cells: identification of α-enolase as a candidate plasminogen receptor,” Biochemistry, vol. 30, no. 6, pp. 1682–1691, 1991. View at Scopus
  35. B. Arza, J. Félez, R. Lopez-Alemany, L. A. Miles, and P. Muñoz-Cánoves, “Identification of an epitope of α-enolase (a candidate plasminogen receptor) by phage display,” Thrombosis and Haemostasis, vol. 78, no. 3, pp. 1097–1103, 1997. View at Scopus
  36. L. A. Miles, S. B. Hawley, N. Baik, N. M. Andronicos, F. J. Castellino, and R. J. Parmer, “Plasminogen receptors: the sine qua non of cell surface plasminogen activation,” Frontiers in Bioscience, vol. 10, no. 2, pp. 1754–1762, 2005. View at Scopus
  37. S. Lighvani, N. Baik, J. E. Diggs, S. Khaldoyanidi, R. J. Parmer, and L. A. Miles, “Regulation of macrophage migration by a novel plasminogen receptor Plg-R KT,” Blood, vol. 118, no. 20, pp. 5622–5630, 2011. View at Publisher · View at Google Scholar
  38. H. Bai, N. Baik, W. B. Kiosses, S. Krajewski, L. A. Miles, and R. J. Parmer, “The novel plasminogen receptor, plasminogen receptor (KT) (Plg-R(KT)), regulates catecholamine release,” The Journal of Biological Chemistry, vol. 286, pp. 33125–33133, 2011. View at Publisher · View at Google Scholar
  39. Z. Fan, P. J. Larson, J. Bognacki et al., “Tissue factor regulates plasminogen binding and activation,” Blood, vol. 91, no. 6, pp. 1987–1998, 1998. View at Scopus
  40. E. A. Peterson, M. R. Sutherland, M. E. Nesheim, and E. L. G. Pryzdial, “Thrombin induces endothelial cell-surface exposure of the plasminogen receptor annexin 2,” Journal of Cell Science, vol. 116, no. 12, pp. 2399–2408, 2003. View at Publisher · View at Google Scholar · View at Scopus
  41. R. López-Alemany, C. Longstaff, S. Hawley et al., “Inhibition of cell surface mediated plasminogen activation by a monoclonal antibody against α-enolase,” American Journal of Hematology, vol. 72, no. 4, pp. 234–242, 2003. View at Publisher · View at Google Scholar · View at Scopus